Loading blog post…
A complete guide to seborrheic dermatitis — why Malassezia yeast causes flaking and inflammation in sebaceous-rich areas, how seborrheic dermatitis differs from psoriasis and atopic dermatitis, the differences between scalp SD (dandruff) and facial SD (eyebrows, nasolabial folds, beard), evidence-based topical antifungal treatments (ketoconazole 2%, zinc pyrithione, selenium sulfide, ciclopirox), maintenance strategies to prevent relapse, triggers (stress, hormones, immune state), and when seborrheic dermatitis requires medical evaluation.
· By MedSpot Editorial · 6 min read
Seborrheic dermatitis is one of the most common skin conditions — affecting 3–5% of the general population and up to 83% of HIV-positive individuals. It is chronic, relapsing, and manageable but not curable. Here is the complete evidence-based guide.
Malassezia is a genus of lipophilic yeasts that normally colonize human skin as part of the microbiome. In seborrheic dermatitis, Malassezia (primarily M. globosa and M. restricta) overgrows in sebaceous-rich areas and triggers inflammation through:
Why only some people get seborrheic dermatitis: Sebaceous gland activity and Malassezia colonization levels are similar across individuals. The differentiating factor is the immune response — seborrheic dermatitis patients have an exaggerated inflammatory response to the same Malassezia products that non-affected individuals tolerate. This explains the dramatically higher prevalence in immunocompromised individuals.
Malassezia requires sebum-derived lipids for survival (it cannot synthesize certain long-chain fatty acids). The areas of highest sebaceous density — scalp, face (nasolabial folds, eyebrows, glabella, beard area), central chest, and back — are where it thrives. This explains the characteristic distribution of seborrheic dermatitis.
Sebum production: Higher sebum output provides more substrate for Malassezia. Seborrheic dermatitis peaks in infancy (cradle cap — high maternal hormone-driven sebaceous activity), in adolescence (androgen-driven sebum surge), and in adult males (higher lifetime sebum production).
Immune state: Any immunodeficiency dramatically increases severity — HIV, organ transplant, Parkinson's disease (neurogenic inflammation), and malignancy all associate with severe seborrheic dermatitis. Neurological conditions may increase sebaceous activity via autonomic dysfunction.
Stress: Stress increases sebum production via corticotropin-releasing hormone (CRH) acting on sebocytes; also impairs immune regulation. Seborrheic dermatitis reliably flares with stress.
Season: Worse in winter (low humidity, reduced UV — UV has mild antifungal activity; cold drives indoor heating that reduces ambient humidity).
"Dandruff" is mild-moderate scalp seborrheic dermatitis — accelerated scalp cell turnover (turnover cycle reduced from ~28 days to ~7 days) producing visible flakes with or without scalp erythema and pruritus.
Distinguishing from scalp psoriasis:
Zinc pyrithione (ZPT) 1–2%: Antifungal and antibacterial; disrupts fungal membrane transport. Available OTC in most antidandruff shampoos. Use 2–3× per week; leave on the scalp 3–5 minutes before rinsing. Effective maintenance treatment.
Ketoconazole 2% shampoo: Azole antifungal — inhibits ergosterol synthesis in Malassezia cell membrane. Most evidence-based antidandruff treatment; head-to-head studies show superiority to ZPT for moderate-severe disease. Use 2× weekly for 4 weeks to treat; once weekly for maintenance.
Selenium sulfide 1–2.5%: Cytostatic and antifungal; reduces scalp cell turnover rate. Effective for moderate-severe dandruff; some cosmetic concerns (discoloration risk on colored or chemically treated hair).
Ciclopirox 1% shampoo: Broad antifungal; chelates iron and manganese required for fungal metabolism. Prescription in many countries; strong evidence base for seborrheic dermatitis.
Coal tar 0.5–5%: Reduces scalp cell proliferation rate and has antifungal activity. Older, less cosmetically elegant; effective for refractory scalp SD. Not appropriate during pregnancy.
Salicylic acid 2–3%: Keratolytic — softens and removes scale. Not directly antifungal but improves penetration of antifungal actives when used in combination.
Facial SD most commonly involves:
Distinguishing facial SD from rosacea:
Distinguishing from atopic/contact dermatitis:
Ketoconazole 2% cream: Applied to affected areas once daily for 2–4 weeks; then twice weekly for maintenance. Most evidence-supported topical antifungal for facial SD.
Ciclopirox 0.77% cream/gel: Similar efficacy to ketoconazole; prescription.
Low-potency topical corticosteroids (short-term): Hydrocortisone 1% cream provides rapid anti-inflammatory relief for an acute flare. Use for 1–2 weeks maximum on the face — steroids do not treat the underlying Malassezia and long-term use causes skin atrophy, telangiectasia, and steroid-induced rosacea on the face.
Combination approach: Ketoconazole for the antifungal component + short-course hydrocortisone for acute inflammation — then taper to ketoconazole-only maintenance. This mirrors the clinical approach in guidelines.
Calcineurin inhibitors (tacrolimus 0.1%, pimecrolimus 1%): Evidence-based for facial SD — anti-inflammatory without steroid atrophy risk. Appropriate for long-term facial use where repeat steroid use would be problematic.
Zinc pyrithione-containing face products: Washing with ZPT-containing cleansers reduces Malassezia load on the face. Available in bar soaps and liquid washes; useful for mild facial SD maintenance.
Scaling and inflammation of the eyelid margins — a common component of facial SD that is often treated separately:
Seborrheic dermatitis is chronic and relapsing — treatment controls symptoms but does not eliminate the underlying Malassezia colonization. Maintenance is more important than acute treatment:
Scalp: Continue ketoconazole or ZPT shampoo once weekly as maintenance after initial treatment — prevents relapse. Most patients need ongoing maintenance indefinitely.
Face: Ketoconazole cream applied twice weekly to affected areas; or ZPT-containing cleanser used as a face wash 2–3× weekly.
Trigger management: Stress reduction, gentle non-fragrant cleansers, avoiding comedogenic products in sebaceous-rich areas, maintaining consistent skincare routine.
Looking for a seborrheic dermatitis or dandruff consultation? Browse med spa and dermatology providers on MedSpot →